Dimensional Fund Advisors LP Graphite Bio, Inc. Transaction History

Dimensional Fund Advisors LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	BUY	$2.24 - $2.66 $30,067 - $35,705	13,423 Added 13.15%	115,490 $302,000
Q3 2023 Nov 09, 2023	SELL	$2.18 - $2.77 $6,779 - $8,614	-3,110 Reduced 2.96%	102,067 $253,000
Q2 2023 Aug 09, 2023	BUY	$2.47 - $3.38 $131,944 - $180,556	53,419 Added 103.21%	105,177 $273,000
Q1 2023 May 12, 2023	BUY	$1.85 - $3.21 $4,512 - $7,829	2,439 Added 4.95%	51,758 $126,000
Q4 2022 Feb 09, 2023	BUY	$2.82 - $3.59 $109,040 - $138,814	38,667 Added 363.0%	49,319 $163,000
Q3 2022 Nov 10, 2022	BUY	$2.82 - $4.24 $30,038 - $45,164	10,652 New	10,652 $34,000

637K

Ticker GRPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,211,200
Description
Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. It offers GPH101, a gene-edited autologous hematopoietic stem cell product candidate to directly correct the mutation that causes sickle cell disease and restore normal adult hemoglobin expres...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.